d-PD-1/PD-L1,

Dan Liu1,2,3, Jingmei Wang4, Weiming You5

  • 1Department of General Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xian, China.

PubMed
概括

这项研究介绍了SuperPDL1exo,一种口服纳米治疗药物,其向PD-L1以激活抗瘤免疫力. 这种新的方法通过激活细胞毒性T淋巴细胞,证明了抑制结肠癌进展的有效性.